Manufacturing Excellence

WHO-compliant Facilities

CiplaQCIL’s goal is to produce pharmaceutical products of the highest quality that have zero environmental impact, adhere strictly to Good Manufacturing Practices (cGMP) and Good Laboratory Practices (GLP), and numerous other international regulatory standards.

As the largest pharmaceutical manufacturer in East Africa and also one of the largest in Sub-Saharan Africa (SSA), CiplaCQIL is one of the few pharmaceutical manufacturers in SSA to operate a World Health Organization (WHO) cGMP compliant facility that manufactures a range of WHO pre-qualified medicines for treating HIV/AIDS and malaria.

ISO Certified

CiplaQCIL has gone the extra mile to get ISO certifications for Environmental Management Systems (ISO 14001:2015). This helps CiplaQCIL to promote better and clear systems on environmental management and (ISO 45001:2018) Occupation Health and Safety Management Systems. We take pride in holding ourselves accountable against international Environmental Health and Safety standards.

Factory Tour

CiplaQCIL has been focused on aggressive market expansion in the past few years, and as a result, the company has been approved by national regulatory bodies across numerous African countries. It is also listed for approvals in many other markets, including South Africa – the single biggest market for antiretrovirals in the world.

The facility is approved for supply in 31 SSA countries and currently exports to 13 countries in Africa and two in South East Asia. CiplaQCIL’s manufacturing facility has also been expanded to increase production capacity from 80 million to 130 million tablets monthly to meet the demand.